Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

QOL Impaired in Young Adults with Psoriasis

J Dermatolog Treat; ePub 2018 Sep 7; Bronckers, et al

In young adults with psoriasis, substantial quality of life (QOL) impairments were found, according to a recent study. Furthermore, female patients, patients with high body mass index (BMI), or long disease duration in particular tended to experience more difficulties. Researchers conducted an explorative, cross-sectional study in patients with psoriasis aged 18–30 years (n=75 [22 males, 53 females]). Individuals completed a set of questionnaires regarding their health status, achievement of developmental milestones, and work productivity. They found:

  • Median Psoriasis Activity and Severity Index (PASI) and body surface area (BSA), respectively, were 4.4 [4.9] and 4.5 [8.4].
  • Young adults experienced feelings of embarrassment, impairments in physical health and work productivity, and difficulties in social development.
  • Patients with more severe psoriasis, longer disease duration, higher BMI, female patients, and patients closer to their 30s tended to be more affected.
Citation:

Bronckers IMG, van Geel MJ, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB. A cross-sectional study in young adults with psoriasis: Potential determining factors in quality of life, life course and work productivity. [Published online ahead of print September 7, 2018]. J Dermatolog Treat. doi:10.1080/09546634.2018.1506077.

This Week's Must Reads

Dermatomyositis, Negative ANA, and Malignancy Risk, J Am Acad Dermatol; ePub 2018 Nov 17; Hoesly, et al

Head/Neck Melanomas Have High Local Recurrence Risk, J Am Acad Dermatol; ePub 2018 Nov 17; Fix, et al

DOT Laser Offers Low Incidence of Adverse Effects, J Drugs Dermatol; 2018 Nov; Sarnoff, Gotkin, et al

Frontal Fibrosing Alopecia and Severity Factors , Dermatology (Karger); ePub 2018 Nov 22; Mervis, et al

Unsafe Neighborhoods Linked with Higher AD Risk, Ann Allergy Asthma Immunol; ePub 2018 Oct 26; McKenzie, et al

Must Reads in Psoriasis

Genetic Architecture of Psoriasis Explored , J Investig Dermatol Proc; 2018 Dec; Elder

Association Found Between HS and Psoriasis, J Am Acad Dermatol; ePub 2018 Nov 28; Kridin, et al

Ixekizumab Provides Rapid Improvement of Itch, Dermatolog Ther (Heidelb); ePub 2018 Dec; Yosipovitch, et al

Role of IL-17 in Psoriasis Pathogenesis Examined, Clin Rev Allerg Immunol; 2018 Dec; Blauvelt, et al

Ixekizumab: A Safe, Effective Psoriasis Treatment , J Cutan Med Surg; ePub 2018 Nov 18; Georgakopoulos, et al